Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment

Erlend Skaga, Evgeny Kulesskiy, Marit Brynjulvsen, Cecilie J Sandberg, Swapnil Potdar, Iver A Langmoen, Aki Laakso, Emília Gaál-Paavola, Markus Perola, Krister Wennerberg, Einar O Vik-Mo

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number33
JournalClinical and translational medicine
Issue number1
Number of pages15
Publication statusPublished - 30 Dec 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Drug sensitivity
  • Drug sensitivity and resistance testing
  • Glioblastoma
  • Glioblastoma stem cells
  • High-throughput drug screening
  • Individualized medicine
  • Recurrent glioblastoma
  • 3112 Neurosciences
  • 3126 Surgery, anesthesiology, intensive care, radiology

Cite this